Journal of Antimicrobial Chemotherapy (2002) 49, 867-870
© 2002 The British Society for Antimicrobial Chemotherapy
Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model
The Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852, Japan
Received 10 September 2001; returned 4 December 2001; revised 3 January 2002; accepted 22 January 2002.
Fourteen-membered macrolides (e.g. clarithromycin and erythromycin), but not 16-membered macrolides (e.g. josamycin), are effective in diffuse panbronchiolitis. However, there are no studies that have compared the effects of 14- and 16-membered macrolide antibiotics on biofilm formation. Treatment with high-dose clarithromycin (100 mg/kg) resulted in a significant decrease in the number of viable bacteria in an experimental murine model. Josamycin at a dose of up to 100 mg/kg had no effect on the number of viable bacteria in the lung. Our results may explain, at least in part, the clinical efficacy of 14-membered macrolide antibiotics in patients with chronic pneumonia caused by Pseudomonas aeruginosa.
Keywords: macrolide antibiotics, chronic respiratory infection, Pseudomonas aeruginosa, biofilm formation, murine model
* Corresponding author. Tel: +81-95-849-7276; Fax: +81-95-849-7285; E-mail: kyana-ngs{at}umin.ac.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Kohler, J.-L. Dumas, and C. Van Delden Ribosome Protection Prevents Azithromycin-Mediated Quorum-Sensing Modulation and Stationary-Phase Killing of Pseudomonas aeruginosa Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4243 - 4248. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Mashburn, A. M. Jett, D. R. Akins, and M. Whiteley Staphylococcus aureus Serves as an Iron Source for Pseudomonas aeruginosa during In Vivo Coculture J. Bacteriol., January 15, 2005; 187(2): 554 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Schultz Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis J. Antimicrob. Chemother., July 1, 2004; 54(1): 21 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Giamarellos-Bourboulis, T. Adamis, G. Laoutaris, L. Sabracos, V. Koussoulas, M. Mouktaroudi, D. Perrea, P. E. Karayannacos, and H. Giamarellou Immunomodulatory Clarithromycin Treatment of Experimental Sepsis and Acute Pyelonephritis Caused by Multidrug-Resistant Pseudomonas aeruginosa Antimicrob. Agents Chemother., January 1, 2004; 48(1): 93 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimizu, S. Shimizu, R. Hattori, E. C. Gabazza, and Y. Majima In Vivo and In Vitro Effects of Macrolide Antibiotics on Mucus Secretion in Airway Epithelial Cells Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 581 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yanagihara, K. Tomono, Y. Kaneko, Y. Miyazaki, K. Tsukamoto, Y. Hirakata, H. Mukae, J.-i. Kadota, I. Murata, and S. Kohno Role of elastase in a mouse model of chronic respiratory Pseudomonas aeruginosa infection that mimics diffuse panbronchiolitis J. Med. Microbiol., June 1, 2003; 52(6): 531 - 535. [Abstract] [Full Text] [PDF] |
||||




